用新型靶向分子影像方法可视化细菌感染
下一代分子影像为靶向识别细菌感染、空间表征及无创时间监测疾病自然病程和抗生素反应提供独特机会,可克服现有工具如需要生物样本检测及其相关采样偏倚等局限,活菌成像还能揭示细菌体内行为的基本生物学见解。
要点
- 过度使用导致多重耐药「超级细菌」选择,可用治疗选择有限的患者增加。
- 下一代分子影像可靶向识别细菌感染并无创时间监测治疗反应。
核心结论
- 迫切需要新临床工具识别细菌感染并监测抗生素反应,以限制抗生素过度使用并改善整体健康。
研究设计与样本
- 原文未报告研究设计。
主要发现
- 抗生素过度使用导致多重耐药「超级细菌」选择,可用治疗选择有限的患者增加。
- 下一代分子影像可靶向识别细菌感染,实现空间表征及无创时间监测疾病自然病程和治疗反应。
- 新兴无创影像方法可克服现有工具如需要生物样本检测及相关采样偏倚等局限。
- 活菌成像可揭示细菌体内行为的基本生物学见解。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although nearly a century has elapsed since the discovery of penicillin, bacterial infections remain a major global threat. Global antibiotic use resulted in an astounding 42 billion doses of antibiotics administered in 2015 with 128 billion annual doses expected by 2030. This overuse of antibiotics has led to the selection of multidrug-resistant "super-bugs," resulting in increasing numbers of patients being susceptible to life-threatening infections with few available therapeutic options. New clinical tools are therefore urgently needed to identify bacterial infections and monitor response to antibiotics, thereby limiting overuse of antibiotics and improving overall health. Next-generation molecular imaging affords unique opportunities to target and identify bacterial infections, enabling spatial characterization as well as noninvasive, temporal monitoring of the natural course of the disease and response to therapy. These emerging noninvasive imaging approaches could overcome several limitations of current tools in infectious disease, such as the need for biological samples for testing with their associated sampling bias. Imaging of living bacteria can also reveal basic biological insights about their behavior in vivo.
引用
- Chen X, Gallagher F, Sellmyer MA, et al. Visualizing Bacterial Infections With Novel Targeted Molecular Imaging Approaches. J Infect Dis. 2023. PMID: 37788506. doi:10.1093/infdis/jiad078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。